Peter Emerson

Peter is a principal with Deloitte Consulting LLP and the former CEO of Recombinant Data Corp., acquired by Deloitte in October 2012. Peter brings more than 20 years of executive leadership and operational experience to ConvergeHEALTH having previously held positions in marketing, sales, business development, product management, and corporate development with a number of technology companies. He has also served as a General Counsel and has practiced health care and corporate law with firms in Boston and Washington, D.C. with a specialty in data governance, patient privacy, and research consent issues. Peter is a graduate of Harvard Law School, and holds an MA from Oxford University, and a BA from the University of Pennsylvania.